PNC Financial Services Group
IMRX icon

PNC Financial Services Group’s Immuneering IMRX Stock Holding History

PNC Financial Services Group’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,000
Closed -$105K – 5284
2026
Q1 		$105K Hold
20,000
– – ﹤0.01% 2783
2025
Q4 		$132K Hold
20,000
– – ﹤0.01% 2621
2025
Q3 		$140K Hold
20,000
– – ﹤0.01% 2556
2025
Q2 		$67.4K Hold
20,000
– – ﹤0.01% 2948
2025
Q1 		$30.4K Hold
20,000
– – ﹤0.01% 3359
2024
Q4 		$44K Hold
20,000
– – ﹤0.01% 3168
2024
Q3 		$49.8K Sell
20,000
-106
-0.5% -$154 ﹤0.01% 3093
2024
Q2 		$25.7K Buy
20,106
+106
+0.5% +$174 ﹤0.01% 3355
2024
Q1 		$57.8K Hold
20,000
– – ﹤0.01% 2924
2023
Q4 		$147K Hold
20,000
– – ﹤0.01% 2367
2023
Q3 		$154K Buy
+20,000
New +$184K ﹤0.01% 2305

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

PNC Financial Services Group's IMRX Position: Q2 2026 in Review

PNC Financial Services Group sold out of Immuneering (IMRX) in Q2 2026, closing a stake of 20,000 shares — an estimated $105K sold.

PNC Financial Services Group first reported a position in IMRX in Q3 2023 and held it in 11 quarters. The position peaked at $154K in Q3 2023. 111 funds tracked by Wall St. Rank hold IMRX as of Q2 2026.

  • PNC Financial Services Group reported no remaining Immuneering position as of Q2 2026 after selling out during the quarter.
  • PNC Financial Services Group sold 20,000 Immuneering shares in Q2 2026, an estimated $105K.
  • PNC Financial Services Group first reported a position in Immuneering in Q3 2023 and held it in 11 quarters.
  • PNC Financial Services Group's Immuneering position peaked at $154K in Q3 2023.
  • 111 funds tracked by Wall St. Rank held Immuneering as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.